- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Large Granular Lymphocytic in United Kingdom
Total 1415 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); FDA Office of Orphan Products DevelopmentCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Boston Medical CenterCompleted
-
Memgen, LLCCompleted
-
Memgen, LLCCompletedChronic Lymphocytic LeukemiaUnited States
-
University of IowaNational Cancer Institute (NCI); Mayo Clinic; PfizerCompletedChronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Jennifer WoyachPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVNational Institutes of Health (NIH)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Duke UniversityCompletedAging | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterLeudositeTerminatedLymphoma, B-Cell | Lymphoma, T-Cell | Lymphoma, Low-Grade | Leukemia, Lymphocytic, Acute | Leukemia, Lymphocytic, ChronicUnited States
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsBayerTerminatedChronic Lymphocytic LeukemiaUnited States
-
Northwell HealthBayerTerminated
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
SecuraBioCompletedA Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
-
Seema BhatRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingDiffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Recurrent Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Recurrent Small Lymphocytic Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | Prolymphocytic Leukemia and other conditionsUnited States
-
M.D. Anderson Cancer CenterGlaxoSmithKlineCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.CompletedLymphoma | LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedSquamous Cell Carcinoma of the Skin | Recurrent Skin Cancer | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedClear Cell Renal Cell Carcinoma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditionsUnited States, Germany, Italy
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedClear Cell Renal Cell Carcinoma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent... and other conditionsUnited States, Germany
-
AbbVieF. Hoffmann-La Roche Ltd; German CLL Study Group (GCLLSG); Dana-Farber Cancer...RecruitingChronic Lymphocytic Leukemia (CLL)United States, Australia, Austria, Bulgaria, Germany, Italy, Spain, Israel, Brazil, Romania, United Kingdom
-
Iovance Biotherapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
University of Michigan Rogel Cancer CenterActive, not recruitingRelapsed Chronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Genzyme, a Sanofi...CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Anaplastic Large-cell Lymphoma | Low Grade B-cell Lymphoma, Not Otherwise SpecifiedUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy
-
Januario Castro, M.D.GlaxoSmithKlineCompleted
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
University of California, San DiegoCelgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
Bristol-Myers SquibbWithdrawnChronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinCanada, Spain, United States, Austria
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation